Posted Dec. 18, 2012 at 6:53 a.m.

Premium Lock GSK joint venture files new drug application for HIV treatment

Published: 2012-12-18 06:53:00
Updated: 2012-12-18 06:53:00

Aids Research Researchers at UNC Chapel Hill have been awarded a $32 million federal grant to develop ways to cure people with HIV. Image 1 of 2 · Next Image…

ViiV Healthcare, a joint venture of GlaxoSmithKline, Pfizer and Shionogi, files for regulatory approval of its proposed treatment for HIV....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll